Clinical trial

Metvix PDT Versus Vehicle PDT With Aktilite CL128 Lamp in Patients With Actinic…

NCT00304239 · Galderma R&D, Industry · Completed

Key facts

NCT number NCT00304239
Title Metvix PDT Versus Vehicle PDT With Aktilite CL128 Lamp in Patients With Actinic Keratosis on the Face and Scalp
Official title A Multicenter, Double Blind, Vehicle-controlled, Randomized Study of Photodynamic Therapy (PDT) With Metvix 160 mg/g Cream and Aktilite CL128 LED Light in Patients With Multiple Actinic Keratosis on the Face and/or Scalp
Lead sponsor Galderma R&D, Industry
Status Completed
Phase Phase 3
Study type Interventional
Conditions Actinic Keratosis
Intervention type Combination Product
Interventions Metvix-PDT, Vehicle-PDT
Enrollment 131
Start date Mar 13, 2006
Primary completion Jan 23, 2007
Completion Jan 23, 2007
First posted Mar 17, 2006
Last update posted Jul 3, 2023
Countries Germany, United States

At a glance

  • 10–99 Study sites
  • Yes Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies